XTX Topco Ltd Makes New Investment in Inotiv, Inc. (NASDAQ:NOTV)

XTX Topco Ltd acquired a new position in Inotiv, Inc. (NASDAQ:NOTV) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 56,907 shares of the company’s stock, valued at approximately $236,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Kennedy Capital Management LLC purchased a new stake in Inotiv in the 4th quarter valued at about $5,250,000. Vantage Point Financial LLC purchased a new stake in shares of Inotiv in the 4th quarter valued at approximately $1,393,000. Renaissance Technologies LLC boosted its position in shares of Inotiv by 77.9% during the 4th quarter. Renaissance Technologies LLC now owns 304,254 shares of the company’s stock worth $1,260,000 after purchasing an additional 133,190 shares during the period. Perkins Capital Management Inc. purchased a new stake in Inotiv in the fourth quarter valued at approximately $497,000. Finally, Nkcfo LLC acquired a new position in Inotiv during the fourth quarter worth $476,000. Institutional investors and hedge funds own 18.17% of the company’s stock.

Inotiv Stock Performance

NASDAQ NOTV opened at $1.87 on Friday. The company has a debt-to-equity ratio of 2.31, a current ratio of 1.57 and a quick ratio of 1.28. The company has a market cap of $63.05 million, a P/E ratio of -0.41 and a beta of 3.96. The stock has a 50-day moving average of $2.60 and a two-hundred day moving average of $3.25. Inotiv, Inc. has a 1-year low of $1.15 and a 1-year high of $6.48.

Inotiv (NASDAQ:NOTV) last announced its earnings results on Wednesday, February 5th. The company reported ($0.42) earnings per share for the quarter, missing the consensus estimate of ($0.32) by ($0.10). Inotiv had a negative return on equity of 15.41% and a negative net margin of 25.40%. As a group, analysts anticipate that Inotiv, Inc. will post -0.79 EPS for the current year.

Insider Activity

In related news, CEO Robert Jr. Leasure sold 22,700 shares of Inotiv stock in a transaction that occurred on Friday, January 31st. The shares were sold at an average price of $4.15, for a total value of $94,205.00. Following the completion of the transaction, the chief executive officer now owns 1,030,209 shares in the company, valued at $4,275,367.35. The trade was a 2.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Over the last three months, insiders have sold 108,311 shares of company stock worth $425,330. Corporate insiders own 7.80% of the company’s stock.

About Inotiv

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.